Recombinant IL2RA (Daclizumab Biosimilar) anticorps

N° du produit ABIN7795104

L’anticorps Souris Monoclonal anti-IL2RA (Daclizumab Biosimilar) a été validé pour FACS et in vivo. Il convient pour détecter IL2RA (Daclizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant IL2RA (Daclizumab Biosimilar) anticorps (ABIN7795104)

Antigène: IL2RA (Daclizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp IL2RA (Daclizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-IL2RA (Daclizumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Daclizumab Biosimilar, CD25 Monoclonal Antibody

Attributs du produit: Daclizumab Biosimilar uses the same protein sequences as the therapeutic antibody daclizumab. Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90 % ) and murine (10 %) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody. Daclizumab binds with high-affinity to the Tac subunit of the high-affinity IL-2 receptor complex and inhibits IL-2 binding. The IL-2 receptor (Tac) subunit is expressed on activated but not resting lymphocytes.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human CD25

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur IL2RA (Daclizumab Biosimilar)

Antigène: IL2RA (Daclizumab Biosimilar)

Autre désignation: Daclizumab Biosimilar

Classe de substances: Biosimilar